Aceruloplasminemia: Waiting for an Efficient Therapy.

Area of Science:

• Genetics and Metabolism
• Neuroscience
• Hematology

Background:

• Aceruloplasminemia is an ultra-rare hereditary disorder due to defective ceruloplasmin production.
• Ceruloplasmin is crucial for iron homeostasis and has antioxidant functions.
• The disease phenotype is heterogeneous, with early signs like microcytosis and diabetes, and later neurological degeneration.

Purpose of the Study:

• To review the current understanding of aceruloplasminemia.
• To explore pathogenic mechanisms and therapeutic strategies.
• To highlight open questions and future directions.

Main Methods:

• Literature review of aceruloplasminemia research.
• Analysis of pathogenic mechanisms.
• Evaluation of current and prospective therapeutic approaches.

Main Results:

• Aceruloplasminemia involves iron-restricted erythropoiesis and tissue iron overload.
• Neurological and retinal degeneration occur progressively.
• Iron chelation therapy is effective for iron overload but not neurological symptoms.

Conclusions:

• Aceruloplasminemia pathogenesis requires further elucidation, especially regarding diabetes and neurological decline.
• Novel therapies, such as parenteral ceruloplasmin administration, show promise.
• Further research is needed to improve treatment efficacy and patient outcomes.